| Date | Title | | | 12/22/16 | iRhythm Technologies to Present at the 35th Annual J.P. Morgan Healthcare Conference| SAN FRANCISCO, Dec. 22, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming 35th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
iRhythm’s management is scheduled to present on Wednesday, January 11, 2017 at 11:00am PT. Interested parties may access a webcast of the presentation on the “Investor Relations... |
|  | | 12/05/16 | iRhythm Technologies Announces Third Quarter 2016 Financial Results and Provides Full Year 2016 Financial Outlook| SAN FRANCISCO, Dec. 05, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three and nine months ended September 30, 2016.
Recent Highlights
Achieved record revenue of $16.8 million in the third quarter of 2016, an increase of 80% over the same period of the prior year
Completed initial public offering, receiving net proceeds of approxi... |
| | | 11/15/16 | iRhythm Technologies Announces New Study Suggests Extended Continuous Cardiac Monitoring is More Useful than Holter Monitoring for Adult Congenital Heart Disease Patients| Data Presented Today at American Heart Association Scientific Sessions Shows iRhythm Technologies’ Zio® System Leads to More Definitive Arrhythmia Diagnosis
SAN FRANCISCO and NEW ORLEANS, Nov. 15, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announced that study results presented today during the American Heart Association (AHA) Scientific Sessions suggest that extended continuous... |
| | | 11/14/16 | iRhythm Technologies to Report Third Quarter 2016 Financial Results on December 5, 2016| SAN FRANCISCO, Nov. 14, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the third quarter 2016 after the close of trading on Monday, December 5, 2016. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Investors interested in listening to the conference call ma... |
| | | 11/02/16 | iRhythm Technologies to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum| SAN FRANCISCO, Nov. 02, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity Medical Technologies & Diagnostics Forum in New York, NY.
iRhythm Technologies’ management is scheduled to present on November 17, 2016 at 9:30am ET. Interested parties may access a webcast of the presentation on the “Invest... |
| | | 10/25/16 | iRhythm Technologies Announces Full Exercise of Over-Allotment Option and Closing of Initial Public Offering| SAN FRANCISCO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (Nasdaq:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the closing of its initial public offering of 7,238,235 shares of its common stock at a public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 944,117 shares of common stock at the same price solely to cover... |
| | | 10/20/16 | iRhythm Technologies Announces Pricing of Initial Public Offering| SAN FRANCISCO, Oct. 19, 2016 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc., a leading digital health care solutions company focused on the advancement of cardiac care, today announced the pricing of its initial public offering of 6,294,118 shares of its common stock at a public offering price of $17.00 per share, before underwriting discounts. In addition, iRhythm has granted the underwriters a 30-day option to purchase up to an additional 944,117 shares of common stock at the same price sol... |
| | | 05/09/16 | New Study Identifies Link Between Atrial Fibrillation Burden And Higher Risk Of Ischemic Stroke With The Use Of ZIO® Service From iRhythm Technologies| Findings Presented at Heart Rhythm Society Scientific Sessions
SAN FRANCISCO, May 9, 2016 /PRNewswire/ -- iRhythm Technologies, Inc., a leading digital health care
solutions company focused on the advancement of cardiac care, today announced a study that found an increase in burden of atrial
fibrillation (AFib) is independently associated with a higher risk of ischemic stroke and other arterial thromboembolism in p... |
| | | 04/28/16 | iRhythm Technologies Expands ZIO® Service To Include True Atrial Fibrillation Duration Reporting| SAN FRANCISCO, April 28, 2016 /PRNewswire/ -- iRhythm Technologies, Inc., a leading digital
healthcare company focused on the advancement of cardiac care, announced today a significant enhancement of ZIO® Reports. The report now
includes True Atrial Fibrillation (AFib) Duration, the validated amount of time an episode of AFib lasts. The availability of AFib
Duration data, coupled with True AFib Burden data provided by the ZIO® Servic... |
| | | 03/22/16 | New Study Suggests High Burden of Atrial Fibrillation is Associated with Lower Cognitive Function| Use of iRhythm Technologies' ZIO® Patch Helps Determine True Atrial Fibrillation Burden
SAN FRANCISCO, March 22, 2016 /PRNewswire/ -- iRhythm Technologies, Inc. announced today that study
results showed an association between a high burden of atrial fibrillation (AFib) and lower cognitive function. Previous studies have shown
a relationship between AFib, cognitive decline and increased risk of dementia. However, this study, which w... |
| | | 03/14/16 | New Study Advances Understanding of Asymptomatic and Episodic Arrhythmias| Data Presented Today at ACC Scientific Sessions Shows iRhythm Technologies' ZIO® Patch Key to Identifying Undiagnosed Atrial Fibrillation among Elderly SAN DIEGO, March 14, 2015 /PRNewswire/ -- iRhythm Technologies, Inc. announced today data presented during the
American College of Cardiology (ACC) Scientific Sessions, which identified a high burden of paroxysmal, or episodic, arrhythmias among elderly men and
women. Paroxysmal and asymptomatic arrhythmias can lead to adverse outcomes ... |
| | | 02/17/16 | New Data Shows High-Risk Arrhythmias Detected Outside Of Traditional 48-Hour Monitoring Window With The Use Of iRhythm Technologies' ZIO® Service| SAN FRANCISCO, Feb. 17, 2016 /PRNewswire/ -- iRhythm Technologies, Inc., a leading digital health care solutions
company focused on the advancement of cardiac care, today announced a recent study that found that a non-trivial percentage of potentially high-risk
cardiac arrhythmias were identified after the initial 48-hour window that is the typical prescribed wear period for Holter electrocardiographic (ECG)
monitors. The study led by researchers from Kaiser Permanente Northern Ca... |
| | | 01/05/16 | iRhythm Technologies to Present at the 34th Annual J.P. Morgan Healthcare Conference| SAN FRANCISCO, Jan. 5, 2016 /PRNewswire/ -- iRhythm Technologies, Inc., a leading digital health
care solutions company focused on advancing cardiac care, today announced that it will participate in the 34th Annual J.P. Morgan Healthcare Conference,
which will take place from January 11 – 14, 2016 at the Westin St. Francis in San Francisco.Kevin King, Chief Executive Officer of iRhythm Technologies, is
scheduled to present on Monday, January 11 at 3:00pm PT.
About iRhythm... |
| |
|
